Other viral hepatitis

AB1_HEPATITIS_OTHER_VIRAL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B17, B18, B19 Hospital discharge: ICD-9 — 070[4-9] Cause of death: ICD-10 — B17, B18, B19 Cause of death: ICD-9 — 070[4-9] 2 out of 7 registries used, show all original rules.	2601
4. Check minimum number of events None	2601
5. Include endpoints None	2601
6. Filter based on genotype QC (FinnGen only)	2601

Control definitions (FinnGen only)

Control exclude: AB1_VIRAL_HEPATITIS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9
Parent code in ICD-10: B15-B19
Name in latin: Diabetes (mellitus) [obesus/non obesus] adultorum

NAME	AB1_HEPATITIS_OTHER_VIRAL
CONTROL_EXCLUDE	AB1_VIRAL_HEPATITIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B1[7-9]
HD_ICD_9	070[4-9]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B1[7-9]
COD_ICD_9	070[4-9]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other viral hepatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2601	1171	1430
Unadjusted period prevalence (%)	0.53	0.40	0.63
Median age at first event (years)	35.63	33.78	37.15

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2367: Matched controls
23668

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

246.7

323.0

442

N05BA01

ATC

diazepam; systemic, rectal

9.9

323.0

905

1390

T36

ICD-10 Finland

Poisoning by systemic antibiotics

14.2

323.0

607

560

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

259.3

323.0

372

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8779.1

323.0

1822

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

144.3

323.0

407

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

147.5

323.0

352

P19

ICPC

Drug abuse

68.8

323.0

466

N05AH04

ATC

quetiapine; oral

6.9

323.0

1070

2532

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

27.4

323.0

1248

926

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

125.4

305.2

325

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

142.6

305.2

321

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

54.1

303.6

363

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

15.1

292.8

513

426

Z72.2

ICD-10 Finland

Drug use

86.8

285.3

317

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

9.6

283.8

639

878

N05AH03

ATC

olanzapine; systemic

8.6

249.6

601

905

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

152.2

246.1

258

N05CD07

ATC

temazepam; oral

8.9

245.4

575

826

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

1296.1

244.0

234

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

109.8

235.6

255

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

129.4

229.2

244

N03AE01

ATC

clonazepam; systemic

10.7

227.6

470

534

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

211.0

223.6

229

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

194.8

222.4

229

B17.1

ICD-10 Finland

Acute hepatitis C

+∞

217.1

205

N05BA04

ATC

oxazepam; oral

4.6

216.8

983

3186

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

155.2

214.7

225

N07BB01

ATC

disulfiram; oral

9.2

209.9

473

623

N06AX11

ATC

mirtazapine; oral

4.1

209.8

1165

4534

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.8

198.2

461

636

N05AA02

ATC

levomepromazine; systemic

11.0

197.7

400

430

N05BA12

ATC

alprazolam; oral

6.4

192.1

572

1130

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

+∞

187.0

177

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

6.3

186.6

558

1104

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.7

176.2

497

904

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

61.7

164.9

193

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

12.6

164.8

308

277

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

52.6

164.7

198

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

57.6

161.4

191

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

177.2

158.8

165

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

15.7

157.9

267

190

N06AB04

ATC

citalopram; systemic

3.8

152.6

800

2774

N05AX08

ATC

risperidone; systemic

6.4

146.6

422

774

P18

ICPC

Medication abuse

39.8

144.9

184

N05CF01

ATC

zopiclone; oral

3.4

142.2

920

3735

F60.2

ICD-10 Finland

Dissocial personality disorder

69.0

140.0

161

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

102.2

139.9

153

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.2

139.8

629

1881

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

10.2

138.4

288

317

P15

ICPC

Chronic alcohol abuse

9.7

136.4

292

338

F10.20

ICD-10 Finland

Alcohol dependence currently independent

12.0

133.7

255

236

A46

ICD-10 Finland

Erysipelas

4.7

133.6

517

1327

EBA00

NOMESCO Finland

Extraction of tooth

3.0

131.3

1114

5398

C07AA05

ATC

propranolol; systemic

3.5

130.6

755

2772

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

70.6

127.4

146

F10.25

ICD-10 Finland

Alcohol dependence continuous use

14.2

125.4

220

169

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.5

124.8

510

1374

N05BA02

ATC

chlordiazepoxide; systemic

13.7

124.1

222

178

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

429.4

124.0

123

N05AF03

ATC

chlorprothixene; systemic

10.5

122.6

250

263

SPAT1272

SPAT

Drug screening

38.7

122.2

156

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

216.1

119.8

123

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

65.0

116.4

135

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

206.8

114.6

118

D72

ICPC

Viral hepatitis

1151.7

113.6

110

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

41.9

113.2

142

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

58.6

112.8

133

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

+∞

111.3

106

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

16.4

111.0

183

120

N03AG01

ATC

valproic acid; systemic, rectal

5.4

110.4

361

759

F10.24

ICD-10 Finland

Alcohol depence active use

14.1

108.8

191

146

T74.1

ICD-10 Finland

Physical abuse

9.8

108.6

229

255

N06AB06

ATC

sertraline; oral

4.0

108.3

502

1501

K04.5

ICD-10 Finland

Chronic apical periodontitis

3.0

107.9

802

3445

SPAT1265

SPAT

Breathalyser

16.4

107.8

178

117

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

16.1

105.3

175

117

0709X

ICD-9 Finland

Viral hepatitis, Unspecified viral hepatitis without mention of hepatic coma

+∞

103.9

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

8.3

103.7

242

320

N06AX16

ATC

venlafaxine; oral

3.5

102.2

577

2021

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

48.3

101.8

124

N06AB03

ATC

fluoxetine; oral

4.0

101.7

470

1395

N05AD01

ATC

haloperidol; systemic

10.2

100.0

206

219

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

137.2

98.9

105

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

47.1

98.8

121

AA1AD

NOMESCO Finland

CT of head and brain

3.2

98.1

612

2300

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

122.0

97.8

105

N05BE01

ATC

buspirone; oral

9.2

96.9

212

251

XF400

NOMESCO Finland

ECG with 12 standard connections

3.7

96.6

478

1498

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

22.0

96.5

143

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

255.4

96.4

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

29.8

95.8

130

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

8.2

95.1

223

296

WX110

NOMESCO Finland

Local anesthesy

2.7

93.8

1855

13563

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.6

93.2

292

578

F10.09

ICD-10 Finland

Alcohol intoxication UNS

9.2

92.2

201

236

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

12.0

91.3

172

153

N03AX16

ATC

pregabalin; oral

2.9

90.9

672

2816

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.7

90.5

445

1381

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

90.1

999

5317

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.8

89.2

435

1339

N06AA12

ATC

doxepin; systemic

7.0

89.2

234

367

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

236.4

89.1

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

34.8

88.9

116

N05AH02

ATC

clozapine; systemic

7.8

88.1

213

296

F20.9

ICD-10 Finland

Schizophrenia, unspecified

7.9

87.9

211

290

EBA30

NOMESCO Finland

Excision of root of tooth

6.1

87.9

256

462

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.4

85.7

1365

8673

Z22.5

ICD-10 Finland

Carrier of viral hepatitis

+∞

83.8

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

88.0

83.7

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.8

83.6

660

2859

N05AX12

ATC

aripiprazole; systemic

5.1

83.3

282

607

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.6

83.3

318

778

F60.9

ICD-10 Finland

Personality disorder, unspecified

10.9

83.1

164

160

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

9.0

81.5

179

212

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

81.4

441

1468

N06AB10

ATC

escitalopram; oral

2.7

80.5

713

3298

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

15.7

80.3

134

SPAT1227

SPAT

Substance abuse rehabilitation

20.2

79.6

121

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

10.2

79.2

162

169

A06AD11

ATC

lactulose; oral

4.0

79.1

347

967

F61.0

ICD-10 Finland

Mixed personality disorders

9.9

78.9

164

176

N02AX02

ATC

tramadol; systemic, rectal

2.3

78.3

1022

5794

N06AB05

ATC

paroxetine; oral

4.5

78.2

299

730

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

76.2

1128

6768

-1

NOMESCO Finland

2.3

76.1

1035

5960

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

11.1

75.3

147

140

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

14.4

75.2

130

N05CF02

ATC

zolpidem; oral

2.8

74.0

567

2383

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

8.7

73.8

165

201

K02.1

ICD-10 Finland

Caries of dentine

2.3

73.8

1611

11494

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

16.3

73.6

121

P16

ICPC

Acute alcohol abuse

8.9

73.5

162

193

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.9

73.4

335

963

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

8.2

72.3

168

218

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

72.1

528

2153

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.1

72.0

458

1700

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

4.1

71.1

303

818

SPAT1254

SPAT

Administration of medicine

3.4

71.0

395

1330

X59

ICD-10 Finland

Exposure to unspecified factor

2.7

71.0

609

2732

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

99.5

70.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

12.3

70.2

130

111

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

13.1

70.0

126

101

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

243.8

69.7

N05AB01

ATC

dixyrazine; systemic

16.2

68.7

113

SAA01

NOMESCO Finland

Simple examination of mouth

2.3

68.2

1841

14202

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

+∞

68.0

WX290

NOMESCO Finland

Other blockade of nerve

2.1

68.0

1359

9152

N03AX12

ATC

gabapentin; oral

3.0

67.7

449

1710

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.4

66.6

367

1224

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.1

66.0

1456

10166

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

65.9

560

2482

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

76.5

65.5

R4110

NOMESCO Finland

Physiotherapy

2.5

65.1

656

3194

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

+∞

64.9

S01.0

ICD-10 Finland

Open wound of scalp

4.0

63.9

274

741

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

325.5

63.7

S06.0

ICD-10 Finland

Concussion

3.3

63.4

365

1254

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

13.5

63.1

112

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

44.1

62.3

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

167.0

62.3

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

5.9

61.4

180

324

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

98.5

61.2

J01FF01

ATC

clindamycin; systemic

2.3

60.7

728

3843

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

50.1

60.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

60.5

647

3226

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

11.1

60.3

117

110

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

60.1

917

5394

K08.3

ICD-10 Finland

Retained dental root

4.2

59.7

245

635

N05AB03

ATC

perphenazine; systemic, rectal

5.4

59.2

187

368

WX892

NOMESCO Finland

Monitored bed care

4.1

58.1

241

630

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.8

58.0

173

318

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.6

57.9

287

875

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

299.1

57.5

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

106.1

57.1

N03AX09

ATC

lamotrigine; oral

4.1

56.9

241

642

EBA15

NOMESCO Finland

Extraction of large number of teeth

6.0

56.9

165

293

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.6

56.5

174

332

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.1

56.2

160

277

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

53.0

56.2

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

560.8

55.8

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

71.7

55.4

N05CD08

ATC

midazolam; nasal, systemic

11.3

54.6

105

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.1

54.2

181

379

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

88.0

54.1

Y07

ICD-10 Finland

Other maltreatment

11.5

53.7

102

N04AA02

ATC

biperiden; systemic

7.6

53.1

129

179

R50.9

ICD-10 Finland

Fever, unspecified

2.7

52.8

406

1673

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.7

52.8

248

722

N06BA04

ATC

methylphenidate; oral

5.7

52.4

158

294

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

140.7

52.0

A41.9

ICD-10 Finland

Sepsis, unspecified

7.1

51.8

131

193

WYA30

SPAT

22.7

51.6

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

61.5

51.6

Z71.8

ICD-10 Finland

Other specified counselling

2.2

51.4

651

3476

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

3.0

51.2

322

1164

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

74.4

51.2

B18.9

ICD-10 Finland

Chronic viral hepatitis, unspecified

+∞

51.2

K04.0

ICD-10 Finland

Pulpitis

2.7

50.9

390

1603

P29

ICPC

Psychological sympt/compl other

3.5

50.8

262

821

P01

ICPC

Feeling anxious/nervous/tense

2.7

50.6

390

1605

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

5.8

50.5

149

270

K04.7

ICD-10 Finland

Periapical abscess without sinus

3.8

50.4

230

652

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

5.1

50.2

167

348

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

50.1

435

1916

N05AA01

ATC

chlorpromazine; systemic, rectal

8.1

50.0

116

150

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.5

48.9

251

783

N05BA06

ATC

lorazepam; systemic, sublingual

4.7

48.9

176

399

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

48.8

804

4776

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

11.0

48.8

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

13.5

48.8

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

11.6

48.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

48.6

574

2953

N05AD03

ATC

melperone; systemic

12.3

48.4

TKC20

NOMESCO Finland

Catheterisation of bladder

4.2

48.1

192

482

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

7.0

47.9

123

185

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.2

47.8

195

500

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

7.5

47.5

115

159

C03CA01

ATC

furosemide; systemic

2.6

47.3

397

1713

V03AA01

ATC

8.4

47.0

106

131

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

12.4

46.9

K05.31

ICD-10 Finland

Periodontitis pronounced

3.2

46.5

269

916

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.4

46.4

443

2048

K02.9

ICD-10 Finland

Dental caries, unspecified

8.0

46.3

108

141

S18

ICPC

Laceration/cut

2.0

46.2

878

5486

339

Kela drug reimbursment

Product containing buprenorfine and naloxone

239.6

46.1

KMAK

NOMESCO Finland

1.9

46.0

1401

10349

F51.0

ICD-10 Finland

Nonorganic insomnia

2.5

45.9

420

1895

N05AF05

ATC

zuclopenthixol; systemic

9.7

45.7

102

X78

ICD-10 Finland

Intentional self-harm by sharp object

14.7

45.4

S10

ICPC

Boil/carbuncle

3.9

45.3

201

555

T51.0

ICD-10 Finland

Toxic effect: Ethanol

14.1

45.2

X57

ICD-10 Finland

Unspecified privation

7.0

45.2

115

171

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

+∞

44.9

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

41.0

44.8

L17

ICPC

Foot/toe symptom/complaint

2.2

44.4

543

2822

D10

ICPC

Vomiting

3.2

44.3

251

842

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

10.2

44.2

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

18.4

43.8

N05AN01

ATC

lithium; oral

5.3

43.7

139

275

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

63.8

43.3

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

12.8

43.3

R05

ICPC

Cough

2.2

43.2

529

2747

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

48.3

43.0

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

6.4

42.8

117

192

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

8.9

42.8

108

R74

ICPC

Upper respiratory infection acute

1.9

42.5

822

5131

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

42.5

309

1220

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

42.4

634

3583

N06AX03

ATC

mianserin; oral

4.5

42.3

159

376

A01

ICPC

Pain general/multiple sites

3.4

42.2

216

671

M79.6

ICD-10 Finland

Pain in limb

1.9

42.2

790

4871

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

15.3

42.1

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.6

41.5

150

341

P72

ICPC

Schizophrenia

5.5

41.4

128

245

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

12.5

41.2

D11

ICPC

Diarrhoea

2.5

41.0

351

1521

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

145.9

40.9

Z72.1

ICD-10 Finland

Alcohol use

7.8

40.8

127

N06AA06

ATC

trimipramine; systemic

6.6

40.8

108

170

N06AX21

ATC

duloxetine; oral

2.7

40.8

306

1231

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

+∞

40.7

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

37.2

40.1

L12

ICPC

Hand/finger symptom/complaint

2.5

39.9

361

1611

A03

ICPC

Fever

2.2

39.9

495

2575

F39

ICD-10 Finland

Unspecified mood [affective] disorder

6.0

39.8

113

195

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

22.0

39.7

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

53.2

39.6

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

10.6

39.1

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

8.2

39.1

112

IGV01

NOMESCO Finland

Psychiatric network contact

9.2

39.0

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

26.3

39.0

F19.40

ICD-10 Finland

Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures

139.0

38.8

L03.9

ICD-10 Finland

Cellulitis, unspecified

7.0

38.7

145

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

34.0

38.6

P74

ICPC

Anxiety disorder/anxiety state

3.8

38.5

174

487

A02BC02

ATC

pantoprazole; systemic

1.8

38.5

1353

10191

A02BC01

ATC

omeprazole; systemic

2.0

38.3

573

3216

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

16.3

38.3

F20.0

ICD-10 Finland

Paranoid schizophrenia

11.2

38.2

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

85.5

37.9

RS220

NOMESCO Finland

7.9

37.7

115

IFC99

NOMESCO Finland

Other biological psychiatric intervention

40.0

37.6

S76

ICPC

Skin infection other

4.2

37.5

151

382

SPAT1247

SPAT

Outpatient detoxication and monitoring

12.2

37.2

WX002

NOMESCO Finland

Sedation and analgesia

2.3

37.2

411

2020

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

5.4

37.0

115

222

P99

ICPC

Psychological disorders other

4.2

36.9

146

363

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

36.7

382

1826

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.8

36.4

944

6423

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

36.2

235

859

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

18.5

36.2

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

14.5

36.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

35.9

326

1452

N06AX12

ATC

bupropion; oral

2.8

35.9

255

989

T40.2

ICD-10 Finland

Poisoning: Other opioids

81.4

35.9

N07BC51

ATC

buprenorphine, combinations; sublingual

187.8

35.8

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

187.8

35.8

Z01.2

ICD-10 Finland

Dental examination

1.8

35.7

1000

6957

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

4.2

35.7

142

355

F20

ICD-10 Finland

Schizophrenia

10.1

35.3

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

3.1

35.3

208

714

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.3

35.3

191

617

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.9

35.3

119

252

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

34.7

163

471

Y09

ICD-10 Finland

Assault by unspecified means

12.4

34.7

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

5.2

34.7

112

226

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.8

34.6

119

257

A28

ICPC

Limited function/disability NOS

3.0

34.6

217

776

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

12.7

34.6

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

52.1

34.5

T40.1

ICD-10 Finland

Poisoning: Heroin

+∞

34.5

F05.9

ICD-10 Finland

Delirium, unspecified

8.1

34.4

101

N05CD02

ATC

nitrazepam; oral

10.4

34.4

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.7

34.4

256

1021

SFA40

NOMESCO Finland

Replacement of krone of tooth

2.1

34.3

462

2472

P01AB01

ATC

metronidazole; oral, rectal

1.8

34.2

856

5725

F19.39

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS

77.3

33.9

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

33.9

606

3614

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

33.9

190

628

K92.0

ICD-10 Finland

Haematemesis

5.8

33.5

172

N03AF01

ATC

carbamazepine; oral, rectal

3.8

33.5

150

417

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

33.5

1280

9700

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

11.8

32.9

L03

ICPC

Low back symptom/complaint

1.9

32.4

543

3152

J01DB01

ATC

cefalexin; oral

1.8

32.4

1908

16377

B18.0

ICD-10 Finland

Chronic viral hepatitis B with delta-agent

+∞

32.4

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

8.6

32.2

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

16.1

32.1

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.5

32.0

155

459

OAB43

SPAT

0.4

31.9

170

3692

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

114.9

31.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.7

31.6

233

923

WX730

NOMESCO Finland

Conventional respirator

7.2

31.5

112

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

2.2

31.2

344

1679

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

19.2

30.9

SGA01

NOMESCO Finland

Tooth opening as first aid

2.0

30.7

483

2734

RS120

NOMESCO Finland

26.7

30.6

K02.2

ICD-10 Finland

Caries of cementum

4.0

30.5

126

326

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

19.5

30.5

Z01.7

ICD-10 Finland

Laboratory examination

2.4

30.4

270

1184

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

7.6

30.4

IEV99

NOMESCO Finland

Other psychiatric network intervention

12.8

30.3

N01

ICPC

Headache

2.4

30.2

284

1282

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

25.1

30.1

SPAT1240

SPAT

Therapeutic discussion

2.2

30.1

347

1728

Z72.0

ICD-10 Finland

Tobacco use

4.8

29.9

102

219

QCB00

NOMESCO Finland

Suture of skin of upper limb

5.7

29.8

160

K04.1

ICD-10 Finland

Necrosis of pulp

2.3

29.8

311

1477

J01MA12

ATC

levofloxacin; systemic

2.1

29.8

365

1863

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

29.5

389

2047

N06AX05

ATC

trazodone; oral

5.0

29.5

200

WX110

SPAT

3.3

29.5

156

495

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.2

29.0

182

F92.0

ICD-10 Finland

Depressive conduct disorder

13.8

29.0

F40.1

ICD-10 Finland

Social phobias

4.0

29.0

120

311

SPAT1234

SPAT

Support of social functional capacity

4.0

28.9

120

312

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

28.9

250

1080

R02

ICPC

Shortness of breath/dyspnoea

2.5

28.7

251

1089

SPAT1260

SPAT

Consultation of another employee

2.1

28.7

376

1974

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

3.7

28.7

130

365

R11

ICD-10 Finland

Nausea and vomiting

2.8

28.6

200

764

R18

ICD-10 Finland

Ascites

8.5

28.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

28.4

249

1082

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.6

28.3

131

374

D97

ICPC

Liver disease NOS

21.9

28.3

ZXA05

NOMESCO Finland

Left side

1.9

28.2

461

2637

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

7.2

28.2

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

28.1

1407

11225

N02BE01

ATC

paracetamol; systemic, rectal

1.7

28.0

1861

16056

T40.4

ICD-10 Finland

Poisoning: Other synthetic narcotics

64.8

28.0

W25

ICD-10 Finland

Contact with sharp glass

7.9

27.7

F15.9

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, unspecified mental and behavioural disorder

146.7

27.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

27.6

159

536

F61

ICD-10 Finland

Mixed and other personality disorders

11.3

27.6

JN4BD

NOMESCO Finland

Extensive body CT

2.7

27.4

204

810

M54.5

ICD-10 Finland

Low back pain

1.7

27.3

754

5114

SPAT1301

SPAT

No procedures

1.8

27.2

627

4022

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

27.2

158

537

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.6

27.1

215

F11.23

ICD-10 Finland

Addiction-induced dependence is currently independent but uses aversion-inducing medication

76.0

26.8

2920A

ICD-9 Finland

Drug psychoses, Drug withdrawal syndrome

274.0

26.8

B18.8

ICD-10 Finland

Other chronic viral hepatitis

274.0

26.8

R41.0

ICD-10 Finland

Disorientation, unspecified

6.4

26.8

113

S29

ICPC

Skin symptom/complaint other

2.1

26.7

344

1789

3017A

ICD-9 Finland

Personality disorders, Antisocial personality disorder

97.9

26.7

W19

ICD-10 Finland

Unspecified fall

2.5

26.7

222

939

QCA10

NOMESCO Finland

Incision of skin of upper limb

25.0

26.6

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

20.8

26.5

K76.9

ICD-10 Finland

Liver disease, unspecified

7.0

26.4

-50

ICPC

Medication/prescr/renewal

3.9

26.3

113

303

N07BA03

ATC

varenicline; oral

2.7

26.3

187

722

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

7.8

26.3

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

7.4

26.3

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

5.3

26.2

156

S51.8

ICD-10 Finland

Open wound of other parts of forearm

7.5

26.2

K04.08

ICD-10 Finland

Other specified pulpit

2.5

26.1

227

982

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.4

25.8

230

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

4.7

25.8

198

SPAT1280

SPAT

Provision of administrative assistance

73.5

25.8

RS310

NOMESCO Finland

18.9

25.7

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

3.3

25.6

133

417

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021879) Hepatitis B virus core Ab [Presence] in Serum

855

2267

5.13

309.34

1.9

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

558

+∞

307.65

1.2

0.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1188

3429

5.54

307.65

1.9

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

827

1268

9.10

307.65

12.1

1.7

—

(4198724)

289

165

19.58

307.65

5.7

1.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

464

641

8.59

307.65

1.2

1.4

titre

91.3

87.3

0.09

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

847

176.42

307.65

2.1

1.3

iu/ml

1634228.3

—

138

(3028300) Cannabinoids [Presence] in Urine

877

1651

7.51

307.65

12.8

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1253

3800

5.43

307.65

3.3

1.8

1.7

1.4

25.72

1122

3425

(3011288) Drugs identified in Urine by Screen method

870

1075

11.66

307.65

16.3

2.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1812

7305

5.88

307.65

6.1

5.1

g/l

36.1

36.8

5.59

1729

6864

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2103

9409

7.45

307.65

8.8

6.1

umol/l

12.5

11.2

2.90

2026

8934

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1505

4699

6.23

307.65

2.1

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

876

1636

7.57

307.65

12.5

1.7

—

(3027944) Amphetamines [Presence] in Urine

853

1615

7.37

307.65

11.8

1.7

—

(3016879) Cocaine [Presence] in Urine

873

1525

8.11

307.65

12.3

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

718

657

14.71

307.65

12.2

2.2

—

(3027008) Opiates [Presence] in Urine

870

1647

7.43

307.65

12.0

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

922

119

119.48

307.65

2.1

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1562

5951

5.07

307.65

2.6

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

823

1578

7.17

307.65

2.9

2.4

g/l

0.2

23.36

749

1485

(3033658) Prothrombin time (PT) actual/Normal

1410

4742

5.31

307.65

6.7

4.0

89.0

94.1

12.24

1369

4621

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1906

7127

7.27

307.65

6.0

3.3

u/l

54.1

31.3

26.79

1817

6792

(3016650) Hepatitis A virus Ab [Presence] in Serum

363

428

9.69

290.13

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

148

68.17

270.80

5.6

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

344

414

9.42

270.12

1.2

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

167

33.60

259.95

4.1

1.2

iu/ml

25385001.8

—

(42870588) Differential panel, method unspecified - Blood

1469

6527

3.87

252.44

7.3

6.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2335

14679

6.78

238.06

11.6

7.2

u/l

85.3

74.8

16.15

2273

13934

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

482

995

5.72

227.76

1.5

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

735

2198

4.27

220.09

3.8

3.0

umol/l

12.4

7.5

3.77

614

1899

(40758558) Short blood count panel - Blood

1167

4893

3.51

210.05

10.0

7.2

—

(3023368) Bacteria identified in Blood by Culture

1067

4284

3.53

204.80

7.2

4.2

—

(3009508) Creatinine [Moles/volume] in Urine

1222

5432

3.36

197.19

11.1

3.2

mmol/l

7.1

8.6

19.74

1079

4710

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

357

636

6.35

195.86

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

278

383

8.01

193.90

3.5

3.4

umol/l

37.7

34.6

1.03

251

337

(44816559) Phosphatidylethanol [Mass/volume] in Blood

334

564

6.65

193.19

2.1

1.3

—

(3022096) Basophils/100 leukocytes in Blood

1686

9231

3.35

188.49

8.7

6.4

0.7

0.71

1613

8728

(3019069) Monocytes/100 leukocytes in Blood

1725

9588

3.37

187.68

8.9

6.5

8.5

8.4

0.11

1653

9102

(3006315) Basophils [#/volume] in Blood

1794

10208

3.44

187.63

9.1

6.2

e9/l

0.0

0.70

1594

8982

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

623

1837

4.14

187.47

3.2

2.6

u/l

30.8

67.4

0.81

555

1603

(3001604) Monocytes [#/volume] in Blood

1791

10184

3.44

187.45

9.1

6.2

e9/l

0.6

2.37

1592

8977

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

198

183

11.63

186.95

7.1

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

216

227

10.29

186.54

1.1

—

(3006504) Eosinophils/100 leukocytes in Blood

1715

9526

3.35

186.24

8.7

6.3

2.7

2.8

1.60

1639

8990

(3013650) Neutrophils [#/volume] in Blood by Automated count

1937

11584

3.63

185.90

16.3

9.3

e9/l

4.0

0.60

1752

10217

(3013115) Eosinophils [#/volume] in Blood

1822

10553

3.43

183.07

10.2

6.5

e9/l

0.2

1.29

1629

9457

(3019198) Lymphocytes [#/volume] in Blood

1805

10551

3.32

175.25

9.1

6.2

e9/l

2.1

2.0

1.80

1623

9489

(3002030) Lymphocytes/100 leukocytes in Blood

1736

9967

3.23

172.90

8.8

6.3

30.6

29.2

5.12

1656

9433

(3018010) Neutrophils/100 leukocytes in Blood

1713

9825

3.18

169.59

8.6

6.1

54.5

56.4

8.47

1639

9328

(3021589) Normoblasts [#/volume] in Blood

1610

9004

3.07

165.05

12.6

8.8

e9/l

0.0

0.38

1357

7418

(3032080) INR in Blood by Coagulation assay

1276

6407

2.95

157.21

7.2

6.9

inr

1.1

1.90

396

2067

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1374

7338

2.85

148.14

8.3

6.2

mmol/l

1.2

10.70

1276

6740

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

537

1680

3.77

145.65

4.7

3.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

160

172

9.85

135.40

1.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1442

8176

2.71

133.86

9.0

6.7

mmol/l

1.2

11.96

1248

6957

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

186

255

7.78

129.43

28.0

19.6

nmol/l

1384.1

1401.7

0.10

180

248

(3030467) Casts [#/volume] in Urine by Automated count

1006

4825

2.77

129.40

3.3

2.9

e6/l

0.5

0.3

1.12

752

3583

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

150

160

9.89

127.59

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1719

10791

2.75

127.56

7.6

4.7

mmol/l

6.6

0.19

1626

9986

(3002032) Base excess in Venous blood by calculation

463

1435

3.71

126.13

4.6

4.0

mmol/l

1.6

1.9

1.00

366

1173

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

149

160

9.82

126.11

1.1

—

(3018095) Leukocytes [#/volume] in Urine

1203

6376

2.65

125.83

4.0

3.4

e6/l

51.5

61.2

0.35

827

4381

(3021447) Carbon dioxide [Partial pressure] in Venous blood

464

1447

3.69

125.19

4.7

3.9

kpa

5.9

0.06

441

1411

(36304419) Bacteria [Presence] in Urine

992

4823

2.71

122.97

3.2

2.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

196

302

6.94

122.65

3.3

3.5

u/ml

6410.5

100.2

0.73

191

279

(3002582) Erythrocytes [#/volume] in Urine

1055

5317

2.66

121.28

3.3

3.0

e6/l

81.9

87.0

0.04

793

4049

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2208

16070

3.48

120.07

7.1

3.0

u/l

69.9

45.2

21.24

2128

15387

(3000991) Gas panel - Venous blood

439

1362

3.67

119.01

10.5

10.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

168

226

7.88

118.72

1.8

1.6

promille

1.3

1.5

0.44

130

177

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

322

806

4.42

117.72

4.3

4.1

mmol/l

23.9

24.3

1.16

288

737

(3042936) Bacteria identified in Isolate by Culture

642

2545

3.02

116.27

2.7

2.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

487

1653

3.39

114.57

2.2

2.6

g/l

12.9

10.4

22.10

462

1520

(3018418) pH of Serum or Plasma

975

4841

2.62

114.13

4.2

4.0

7.4

1.10

165

951

(3014111) Lactate [Moles/volume] in Serum or Plasma

453

1473

3.51

114.02

9.6

8.2

mmol/l

1.4

1.3

0.55

434

1418

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1101

5825

2.54

112.43

4.0

2.6

u/l

56.2

56.6

0.08

1005

5459

(3003458) Phosphate [Moles/volume] in Serum or Plasma

563

2142

3.08

108.97

7.7

6.8

mmol/l

1.0

0.40

541

2019

(3007463) Buprenorphine [Presence] in Urine

111

231.77

108.53

10.3

3.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

409

1290

3.58

107.55

1.4

1.8

g/l

1.6

1.3

2.99

382

1205

(3024354) Oxygen [Partial pressure] in Venous blood

382

1177

3.63

103.91

4.3

3.2

kpa

5.2

4.8

2.85

360

1145

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

644

2723

2.81

102.12

2.8

2.7

e6/l

3.3

2.3

1.53

321

1435

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

663

2889

2.74

98.82

2.7

2.5

e6/l

1.4

1.1

0.73

336

1591

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1133

6354

2.39

98.48

2.0

1.8

pmol/l

95.6

97.2

0.56

597

3552

(3037522) Nuclear Ab [Titer] in Serum

670

2993

2.67

94.56

1.4

titre

305.7

498.3

3.71

140

555

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

959

5078

2.41

94.00

2.9

2.1

u/l

384.2

263.1

1.16

912

4833

(3031040) Bacteria [#/volume] in Urine by Automated count

1755

12047

2.40

93.28

4.8

3.6

e6/l

153.7

1068.5

1.17

136

(3003396) Base excess in Arterial blood by calculation

468

1761

3.02

91.09

10.4

9.3

mmol/l

0.8

0.9

0.24

379

1382

(3027974) Hepatitis B virus e Ag [Presence] in Serum

124.55

89.58

2.2

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

458

1724

3.01

88.94

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

463

1761

2.98

88.21

2.1

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

627

2795

2.64

88.16

4.1

3.8

mmol/l

0.8

7.85

583

2649

(3015736) pH of Urine

1234

7453

2.25

86.93

5.9

2.8

—

5.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

585

2537

2.68

86.81

2.1

1.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

157.09

86.64

2.2

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

500

2004

2.85

86.39

10.3

7.7

mmol/l

104.5

104.4

0.32

484

1968

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

313

960

3.57

85.03

1.4

1.3

miu/ml

186.1

217.5

0.59

456

(3007853) Bacteria identified in Skin by Aerobe culture

540

2274

2.73

84.73

2.1

1.7

—

(3026782) Osmolality of Urine

698

3362

2.47

82.73

2.9

2.6

mosm/kgh2o

531.5

561.1

2.44

608

2889

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

454

1768

2.90

82.48

10.6

9.2

kpa

5.3

5.1

3.59

433

1698

(3027801) Oxygen [Partial pressure] in Arterial blood

454

1768

2.90

82.48

10.6

9.2

kpa

11.7

13.0

6.76

434

1703

(3022217) INR in Platelet poor plasma by Coagulation assay

440

1726

2.86

78.61

9.3

16.0

inr

1.1

1.2

1.99

279

(3020779) Urea [Moles/volume] in Serum or Plasma

391

1453

2.99

77.02

8.0

9.0

mmol/l

8.3

8.2

0.10

376

1402

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

269

820

3.54

73.42

12.3

12.0

mmol/l

24.3

0.09

250

782

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

216

570

4.04

72.68

2.3

2.4

ug/l

669.9

307.3

1.16

205

538

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

9.44

72.46

1.5

3.2

umol/l

161.2

141.7

0.15

(3000850) Epithelial cells [#/volume] in Urine

707

3615

2.31

71.78

2.7

2.5

e6/l

11.5

5.6

1.65

634

3191

(3002173) Hemoglobin [Mass/volume] in Arterial blood

382

1472

2.87

70.07

11.5

10.1

g/l

121.0

125.6

3.56

373

1425

(3016502) Oxygen saturation in Arterial blood

397

1567

2.81

69.58

11.4

9.9

95.2

96.2

2.57

389

1518

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

262

815

3.46

69.19

1.9

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

501

2237

2.54

68.52

2.5

22.8

24.7

1.57

438

1948

(3019550) Sodium [Moles/volume] in Serum or Plasma

2445

20768

3.96

68.36

24.2

11.9

mmol/l

138.9

139.7

45.11

2399

20252

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

137

7.47

67.98

13.7

8.3

u/ml

1154.2

15387.9

0.47

(3023103) Potassium [Moles/volume] in Serum or Plasma

2448

20857

3.95

67.09

24.2

12.0

mmol/l

4.0

0.03

2399

20292

(3018677) aPTT in Platelet poor plasma by Coagulation assay

547

2576

2.42

66.46

2.6

2.4

30.6

29.7

2.59

534

2496

(3019150) Specific gravity of Urine by Refractometry

761

4124

2.19

66.27

7.3

3.2

kg/l

1.0

1.15

557

(3004789) Transferrin [Mass/volume] in Serum or Plasma

522

2419

2.45

65.65

2.4

g/l

2.4

0.26

477

2254

(3015377) Calcium [Moles/volume] in Serum or Plasma

934

5513

2.08

64.83

3.1

3.2

mmol/l

2.3

0.65

817

4987

(3026008) Bacteria identified in Urine by Culture

759

4203

2.14

61.86

3.3

2.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

658

3447

2.22

61.73

1.6

1.4

nmol/l

18.4

20.1

2.82

595

3049

(3009466) Valproate [Moles/volume] in Serum or Plasma

165

404

4.29

61.24

5.7

6.4

umol/l

356.5

380.1

1.15

143

351

(3037467) Urinalysis macro (dipstick) panel - Urine

1776

13344

2.04

60.56

4.7

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

750

4168

2.12

60.32

2.3

2.1

mg/l

2.9

2.8

0.66

649

3628

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

621

3228

2.21

59.06

3.7

3.3

ng/l

258.1

527.5

1.84

400

2102

(3013707) Erythrocyte sedimentation rate by Westergren method

1883

14522

2.07

58.75

4.1

3.7

mm/h

12.8

9.1

20.25

1743

13657

(3044640) Blood type and Crossmatch panel - Blood

943

5755

2.00

58.31

3.1

2.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

367

1519

2.65

58.05

2.9

2.8

1.9

1.8

1.00

317

1388

(3022948) Iron [Moles/volume] in Serum or Plasma

530

2614

2.29

57.06

2.4

umol/l

13.5

14.5

1.85

496

2436

(40768441) Liver Pathology biopsy report

143

6.56

55.55

1.5

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

531

2649

2.26

55.47

2.7

2.9

mmol/l

2.4

3.84

452

2330

(3023511) Choriogonadotropin [Units/volume] in Urine

198

597

3.51

54.60

1.7

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

505

2484

2.28

54.48

1.8

1.7

nmol/l

1110.5

1167.0

0.67

381

1965

(3002385) Erythrocyte distribution width [Ratio]

2214

18387

2.37

54.17

30.9

13.5

13.8

13.4

22.49

2195

18024

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

392

1731

2.49

53.97

3.3

4.5

u/l

239.3

235.7

0.18

370

1650

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

266

982

2.90

52.18

1.6

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

134

6.52

51.72

2.6

2.3

nmol/l

145.7

155.0

0.29

114

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

690

3907

2.04

51.51

2.6

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

240

849

3.01

50.79

12.1

12.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

107

214

5.17

50.77

1.3

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

151

6.07

50.37

3.2

2.8

35.3

44.5

3.09

(1761868) Lipid panel - Serum or Plasma

556

9342

0.49

49.11

2.8

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

735

4344

1.96

48.07

2.9

2.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2424

21289

3.04

47.67

22.4

11.2

mg/l

23.9

21.5

3.38

2064

16370

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

731

4324

1.96

47.61

2.7

2.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

135

348

4.04

46.67

3.2

2.1

titre

2060.0

1343.3

0.29

(3052851) Hemolysis interference index of Serum or Plasma

169

510

3.47

46.45

2.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

159

465

3.58

45.84

4.2

6.9

iu/ml

1301.4

737.0

0.42

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2300

19790

2.40

45.54

19.2

9.8

ml/min/173m2

95.6

91.3

15.75

1948

16299

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

183

593

3.24

44.87

4.4

3.5

mg/l

1.4

0.35

178

558

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

125

318

4.08

43.99

1.8

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

347

3.92

43.60

2.7

3.3

u/ml

700.7

1953.1

0.58

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2208

18773

2.17

43.55

5.2

4.3

mu/l

1.8

2.0

1.04

2054

17636

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

181

5.11

42.42

1.2

1.3

titre

385.0

253.5

0.34

(3011397) Hemoglobin [Presence] in Urine by Test strip

698

4205

1.90

42.23

3.2

3.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

12.61

41.84

8.0

11.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

102

231

4.55

41.74

6.1

6.8

mg/l

9.6

10.2

0.76

216

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

218

4.58

40.07

13.0

12.4

mmol/l

0.6

0.43

198

(3004119) Hemoglobin [Mass/volume] in Venous blood

233

920

2.68

39.94

4.8

3.3

g/l

131.1

133.9

0.99

227

903

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

10.16

39.85

1.3

—

(3024928) Oxygen saturation in Venous blood

126

354

3.69

38.53

4.4

3.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

716

4460

1.84

38.40

1.5

g/l

2.6

2.4

2.94

476

2965

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

168

577

3.04

37.26

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

118

325

3.76

37.14

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

118

325

3.76

37.14

1.3

—

(3017509) Phencyclidine [Presence] in Urine

10.68

36.69

4.7

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

170

597

2.98

36.25

1.7

1.9

g/l

1.4

1.5

0.15

140

523

(21494755) Public health laboratory ask at order entry panel

136

3669

0.34

36.13

1.2

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

191

4.62

36.05

2.3

2.9

e6/l

837.1

718.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

11.36

35.37

2.8

4.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

153

521

3.06

34.42

1.3

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2499

22899

3.33

34.31

17.9

8.9

u/l

44.9

29.4

47.99

2473

22303

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1206

8933

1.65

33.51

4.6

3.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

131

420

3.23

32.62

3.9

2.5

titre

16.6

3.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1881

15684

1.72

32.36

4.1

3.7

pmol/l

14.5

0.23

1729

14599

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

111

322

3.56

32.36

1.1

g/l

1.7

1.4

6.43

100

295

(3044889) 12 lead EKG panel

1670

13509

1.66

32.10

3.8

3.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

155

553

2.92

32.09

1.3

1.2

u/ml

261.2

246.5

0.24

121

357

(3023520) Reticulocytes [#/volume] in Blood

238

1063

2.36

31.25

2.5

2.9

e9/l

78.2

73.7

0.64

153

795

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

195

796

2.57

31.11

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

142

492

3.00

30.98

1.4

1.5

u/ml

118.7

116.3

0.08

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1052

7668

1.62

30.19

2.5

2.3

nmol/l

67.2

72.8

8.85

974

7146

(3037121) Protein [Mass/volume] in Urine

161

607

2.76

30.07

4.3

3.5

g/l

0.3

0.23

111

291

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

163

621

2.73

29.84

3.4

2.9

g/l

3.5

3.6

0.21

158

588

(3036180) Methadone [Presence] in Urine

66.74

28.94

5.2

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

143

521

2.85

28.48

2.0

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

141

4.70

28.06

3.6

4.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.28

27.91

3.2

—

(40768797) Stomach Pathology biopsy report

425

2474

1.86

27.27

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

127

456

2.88

25.98

2.6

2.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

207

954

2.27

25.16

1.3

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

127

3028

0.39

24.88

1.5

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

1236

9646

1.54

24.74

3.6

3.1

estimate

0.0

0.80

261

1795

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

673

4569

1.64

24.68

2.1

1.8

mg/l

1.4

0.9

1.12

515

3327

(3027273) Bicarbonate [Moles/volume] in Venous blood

162

686

2.45

23.86

4.6

3.6

mmol/l

24.9

25.2

0.59

156

667

(3021601) Nitrite [Presence] in Urine by Test strip

1231

9654

1.52

23.73

5.0

4.2

estimate

0.0

0.50

266

1865

(3009261) Glucose [Presence] in Urine by Test strip

1239

9737

1.52

23.61

3.6

3.1

estimate

0.0

0.80

263

1769

(3008152) Bicarbonate [Moles/volume] in Arterial blood

202

960

2.20

22.76

10.4

8.4

mmol/l

24.7

24.5

0.29

191

898

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1168

9113

1.51

22.73

3.1

2.8

ug/l

132.9

112.1

1.47

1073

8625

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

235

1187

2.08

22.63

1.6

1.7

—

(3010421) pH of Blood

124

477

2.68

22.27

4.5

4.0

7.4

4.75

107

398

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

129

508

2.62

22.12

3.3

4.0

u/ml

73.8

2742.6

0.76

111

439

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

141

581

2.51

22.02

2.4

2.2

ug/l

1.3

1.8

0.36

130

530

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

6.14

21.57

4.8

2.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

322

3.02

21.57

1.5

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

374

2247

1.78

21.27

2.5

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

235

1216

2.03

21.16

2.8

2.5

u/l

5031.3

5450.1

0.07

487

(3035947) Staphylolysin Ab [Units/volume] in Serum

4.91

21.09

1.2

1.1

iu/ml

5.4

4.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

711

5047

1.56

21.07

1.6

mmol/l

1.6

1.5

1.41

647

4399

(3000093) Morphology [Interpretation] in Blood Narrative

145

4.07

20.96

1.1

—

(3012501) Base excess in Blood by calculation

109

405

2.77

20.95

4.7

4.1

mmol/l

2.1

2.2

0.10

265

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

311

1780

1.85

20.74

2.4

1.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

147

637

2.39

20.58

5.5

2.7

180.8

172.9

0.42

140

612

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

158

709

2.31

20.43

3.3

2.5

84.5

94.1

4.79

151

664

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

349

2.85

19.81

1.7

1.9

g/l

0.0

0.00

326

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

102

380

2.75

19.52

2.0

1.9

g/l

0.0

0.63

357

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

108

417

2.66

19.28

2.3

2.0

g/l

0.7

0.00

382

(1616796) Gas panel - Central venous blood

102

383

2.73

19.23

4.2

3.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

101

379

2.73

19.06

1.8

1.9

g/l

37.9

38.8

0.57

339

(40761511) CBC panel - Blood by Automated count

2424

22629

2.05

19.03

20.2

10.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

346

2.81

18.98

1.8

1.9

g/l

0.0

0.00

325

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

175

3.60

18.91

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

184

3462

0.50

18.90

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

214

1119

1.99

18.68

2.3

2.5

g/l

67.6

67.5

0.05

198

1051

(3000494) Fungus identified in Specimen by Culture

378

2359

1.70

18.64

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

452

2.54

18.29

2.0

1.9

g/l

12.8

10.4

3.53

102

395

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

496

2.47

18.16

2.2

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

496

2.47

18.16

2.2

1.8

g/l

3.6

3.9

1.23

361

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

496

2.47

18.16

2.2

1.8

g/l

7.4

7.2

0.70

383

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2165

19635

1.61

17.95

4.7

3.7

mmol/l

6.1

5.8

9.45

1999

18402

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

845

6427

1.47

17.34

3.9

2.9

ng/l

57.3

38.9

0.32

508

3591

(3019060) Gas panel - Arterial blood

191

988

2.01

17.17

7.4

6.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

109

448

2.50

17.15

3.2

3.9

u/ml

0.3

1.15

234

(40767503) Oxygen content in Capillary blood by calculation

348

2.70

17.12

3.2

2.5

16.4

17.3

1.19

178

(3023199) Leukocytes [#/volume] in Pleural fluid

109

4.18

16.99

1.6

1.4

e6/l

27505.9

2414.3

0.57

(3044007) Cell count panel - Peritoneal fluid

6.28

16.74

3.1

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.34

16.65

1.7

1.4

e6/l

32688.6

23538.3

0.26

(3011648) Oxygen content in Venous blood

147

3.66

16.61

4.4

2.7

11.2

11.4

0.14

147

(3021387) Prolactin [Units/volume] in Serum or Plasma

217

1191

1.90

16.40

1.7

1.6

mu/l

377.0

280.0

2.80

181

1085

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

299

2.80

16.38

1.4

1.6

—

(3036489) Thrombin time

160

791

2.09

16.28

3.4

2.3

22.4

21.2

2.67

146

690

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

110

469

2.40

16.00

2.2

1.9

g/l

3.1

3.0

0.34

371

(3045788) Cell count panel - Pleural fluid

4.43

15.90

1.7

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2062

0.41

15.88

1.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

5.21

15.80

2.5

2.4

e6/l

259.9

702.4

1.26

(3033799) Differential panel - Peritoneal fluid

6.05

15.59

2.7

2.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

190

1019

1.93

15.39

3.7

3.3

kpa

5.3

5.2

1.30

180

960

(3012516) Albumin [Mass/volume] in Urine

624

4563

1.48

15.30

3.4

mg/l

219.7

377.9

0.63

389

3039

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

183

971

1.95

15.30

3.6

3.3

mmol/l

1.8

1.5

0.48

138

712

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.82

14.86

1.7

1.4

g/l

98.5

22.5

0.41

(3020682) Albumin/Creatinine [Ratio] in Urine

646

4780

1.47

14.85

4.2

4.1

mg/mmol

22.8

10.0

2.51

405

3171

(3009343) pH of Capillary blood

186

1008

1.91

14.60

3.6

3.3

7.4

0.87

135

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

5.43

14.48

2.6

2.2

e6/l

690.4

3266.5

1.15

(3012441) Differential panel - Pleural fluid

110

3.86

14.32

1.5

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.97

14.02

2.0

1.1

mg/l

64.6

44.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

481

3393

1.51

13.91

1.9

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

100

437

2.34

13.80

4.3

4.1

53.6

56.4

1.62

100

437

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

222

1298

1.78

13.66

3.4

4.5

ug/l

8.8

22.7

0.99

194

1021

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

126

611

2.12

13.51

6.7

6.8

2.5

1.7

5.44

118

573

(3006184) Hemoglobin [Mass/volume] in Capillary blood

362

2.45

13.39

2.4

2.2

g/l

129.3

135.3

1.21

270

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

500

3588

1.49

13.24

2.9

3.0

ng/l

1706.2

929.9

0.91

416

2931

(3009214) Lutropin [Units/volume] in Serum or Plasma

179

991

1.87

13.16

1.4

u/l

7.6

7.8

0.09

124

805

(3051651) Icteric interference index of Serum or Plasma

109

3.71

12.92

3.4

3.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

408

2.33

12.74

3.5

2.7

mmol/l

24.7

24.6

0.04

365

(3009542) Hematocrit [Volume Fraction] of Blood

2265

21126

1.56

12.70

28.1

11.6

40.1

41.4

13.37

1722

17410

(3007930) Methemoglobin/Hemoglobin.total in Blood

123

607

2.08

12.61

6.8

6.9

0.9

0.06

115

571

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

439

2.26

12.37

1.5

1.8

—

(3021901) Oxygen saturation in Capillary blood

286

2.56

12.24

2.9

2.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

190

2.94

12.20

2.5

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

160

883

1.87

11.90

2.1

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

4.26

11.73

1.4

1.5

ug/l

12.5

8.1

2.71

(40761536) Microorganisms panel - Urine sediment

266

1702

1.63

11.70

4.0

3.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.12

11.59

1.2

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.12

11.59

1.2

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

4.54

11.42

1.2

1.0

—

(3017181) Myelocytes/100 leukocytes in Blood

252

1605

1.63

11.29

4.7

4.5

0.6

0.9

1.43

434

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

182

1063

1.77

11.24

2.8

2.9

ng/l

171.2

139.9

0.40

162

930

(3020891) Body temperature

122

628

1.99

11.17

8.6

5.0

—

(3013762) Body weight Measured

8.79

11.12

1.1

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1590

0.44

11.06

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

436

2.18

10.92

1.7

1.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

212

1303

1.68

10.90

4.4

3.8

mmol/l

1.2

2.75

190

1128

(3017446) Testosterone [Moles/volume] in Serum or Plasma

347

2401

1.51

10.82

2.7

2.3

nmol/l

13.5

13.7

0.20

287

2201

(3051611) Lipemic interference index of Serum or Plasma

149

3.06

10.78

3.4

3.5

—

(3019977) pH of Arterial blood

3.98

10.75

3.0

3.4

7.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

103

507

2.07

10.67

1.4

ug/g

249.5

302.2

1.96

278

(3047181) Lactate [Moles/volume] in Blood

104

518

2.05

10.45

7.5

7.8

mmol/l

1.3

1.2

0.11

452

(3029937) Albumin [Presence] in Urine by Test strip

642

5006

1.38

10.43

4.0

3.4

estimate

0.0

1.49

256

1808

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

102

506

2.06

10.36

1.8

1.4

e6/l

30.3

17.4

0.58

390

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

102

506

2.06

10.36

1.8

1.5

e6/l

35803.1

1355.0

0.49

408

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

7.81

10.14

2.5

2.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

184

1113

1.70

10.05

4.7

4.3

ng/l

98.2

83.6

1.14

168

1011

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.68

9.97

2.2

1.9

—

(3007461) Platelets [#/volume] in Blood

2526

24455

2.14

9.95

36.2

16.2

e9/l

238.0

254.1

22.50

2488

23949

(3003181) Sodium [Moles/volume] in Urine

242

2.51

9.95

1.7

1.3

mmol/l

49.9

67.5

1.66

202

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2009

18540

1.37

9.86

5.7

4.6

mmol/mol

38.5

38.6

0.08

1868

17623

(3002179) Metamyelocytes/100 leukocytes in Blood

230

1482

1.61

9.82

4.5

4.3

0.5

0.6

0.27

320

(3043409) Potassium [Moles/volume] in Arterial blood

469

2.06

9.79

7.4

4.6

mmol/l

3.8

3.9

0.27

446

(3034860) Kappa light chains.free [Mass/volume] in Serum

357

2.22

9.75

2.4

3.1

mg/l

54.9

70.5

0.36

280

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

351

2.23

9.72

2.4

3.1

ratio

3.6

3.1

—

(40768806) Pleura Pathology biopsy report

112

3.25

9.58

1.5

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

304

2.30

9.45

1.3

2.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

234

1530

1.58

9.40

4.9

4.6

0.0

0.1

2.62

399

(3024731) MCV [Entitic volume]

2526

24489

2.09

9.35

36.0

16.1

90.5

90.1

5.02

2512

24242

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

357

2.19

9.34

2.4

3.1

mg/l

42.8

32.9

0.76

279

(3025159) Blasts/100 leukocytes in Blood

224

1452

1.59

9.33

5.0

4.6

0.1

0.6

0.82

333

(3035941) MCH [Entitic mass]

2526

24490

2.09

9.33

36.0

16.1

30.3

30.2

1.36

2512

24241

(3026361) Erythrocytes [#/volume] in Blood

2526

24494

2.08

9.26

36.1

16.2

e12/l

4.5

4.7

30.28

2480

23960

(3039000) Anion gap in Blood

354

2.18

9.12

8.9

9.8

mmol/l

10.9

11.5

0.72

322

(3010813) Leukocytes [#/volume] in Blood

2526

24505

2.07

9.07

36.3

16.2

e9/l

7.1

6.7

15.96

2481

23957

(3018572) Chloride [Moles/volume] in Blood

355

2.18

9.06

8.9

9.8

mmol/l

104.3

105.3

0.81

323

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.59

9.06

2.8

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.59

9.06

2.8

3.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

342

2.20

9.06

1.1

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

2526

24506

2.07

9.05

36.4

16.3

g/l

135.8

140.1

34.81

2510

24254

(40760888) Immunoglobulin light chains.free panel - Serum

274

2.33

8.90

2.6

3.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

251

2.38

8.77

1.4

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

506

1.95

8.62

1.2

1.3

mmol/l

3.8

3.7

0.24

472

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

6.39

8.53

2.5

2.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

147

876

1.72

8.51

2.3

2.0

pmol/l

188.6

214.2

1.84

141

838

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

189

1213

1.60

8.22

2.2

ug/l

11.0

8.2

0.51

168

1100

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

626

5019

1.33

8.19

1.3

u/ml

1.6

1.7

0.05

114

1448

(3044290) Cell count panel - Cerebral spinal fluid

480

1.95

8.19

1.9

1.5

—

(3013512) EKG study

563

4461

1.33

7.97

3.9

3.1

—

(44790049)

231

2.37

7.96

1.5

1.7

—

(44790047)

231

2.37

7.96

1.5

1.7

—

(44806118)

231

2.37

7.96

1.5

1.7

—

(44790048)

231

2.37

7.96

1.5

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

104

572

1.85

7.90

1.3

mg/l

547.1

493.3

0.33

542

(3034274) Bile acid [Moles/volume] in Serum --fasting

362

2.07

7.88

3.2

2.4

umol/l

12.5

6.1

0.72

265

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.84

7.25

1.8

1.1

100.8

93.4

0.50

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.84

7.25

1.8

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

313

2.10

7.24

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

105

2.98

7.23

1.2

1.1

iu/ml

330.9

240.6

0.53

105

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

116

2.87

7.21

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.90

7.15

1.7

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

383

1.99

7.14

1.7

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

275

1973

1.44

7.08

8.6

5.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

140

2.67

7.06

1.5

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

257

2.20

7.05

2.9

3.4

1.1

1.3

0.14

211

(40760892) CBC W Ordered Manual Differential panel - Blood

627

5119

1.30

7.05

7.0

4.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

456

3581

1.33

6.77

1.3

iu/ml

32.2

27.9

0.44

163

1108

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

179

1190

1.54

6.72

2.2

1.9

nmol/l

48.9

36.0

8.41

167

1165

(3008757) Leukocyte morphology finding [Identifier] in Blood

162

2.49

6.68

2.8

4.0

—

(3023410) Appearance of Cerebral spinal fluid

244

2.20

6.64

2.4

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

158

2.49

6.52

3.8

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

591

0.32

6.51

1.4

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.94

6.42

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.94

6.42

3.4

1.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

6.69

6.31

1.0

1.3

—

(36660697) Celiac disease serology panel - Serum

246

1767

1.43

6.30

1.1

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

213

1489

1.47

6.29

3.4

2.3

ml/min/173m2

69.1

75.9

1.20

537

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.02

6.22

1.1

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

271

2.09

6.21

1.5

—

(4281824)

138

2.56

6.20

1.4

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

234

2.16

6.05

1.4

iu/ml

17.3

28.0

—

(40761535) Cells panel - Urine sediment

193

1334

1.48

6.04

3.5

3.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.25

6.00

1.5

2.3

umol/l

15.7

15.4

0.05

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.88

5.98

1.6

1.7

g/l

7.7

10.8

0.73

(40759836) Histone Ab [Presence] in Serum by Immunoblot

160

2.40

5.88

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

160

2.40

5.88

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

2.40

5.88

1.2

1.1

—

(3003338) MCHC [Mass/volume]

2083

19724

1.28

5.87

32.7

13.7

g/l

333.6

334.5

4.04

2073

19583

(3024980) IgG subclass 4 [Mass/volume] in Serum

382

1.88

5.86

1.5

1.7

g/l

0.7

0.8

0.68

295

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

231

2.14

5.83

1.4

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.66

5.73

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

114

2.65

5.73

26.2

26.4

ug/l

104.7

119.5

0.65

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

162

2.37

5.73

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

162

2.37

5.73

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

162

2.37

5.73

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.77

5.63

1.1

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

265

1969

1.39

5.60

2.2

2.1

nmol/l

355.8

369.7

0.64

240

1832

(3024891) Influenza virus A+B Ag [Presence] in Specimen

108

674

1.63

5.36

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

234

2.07

5.27

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

346

1.87

5.25

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

250

2.02

5.14

1.3

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

419

3381

1.29

5.02

1.7

1.6

pmol/l

44606892.9

36373269.4

0.09

343

2961

(3052592) Norovirus Ag [Presence] in Stool

4.80

5.01

2.9

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

173

2.21

4.97

1.3

1.2

u/l

65.5

59.4

0.33

119

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

206

2.11

4.96

1.4

1.8

—

(3025130) Human papilloma virus identified in Specimen

310

1.89

4.94

1.8

1.7

—

(4035726)

197

1423

1.42

4.93

1.5

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

248

1.99

4.89

2.4

1.4

—

(3022313) Gas panel - Capillary blood

112

724

1.57

4.84

3.7

3.5

—

(4010399)

178

1267

1.43

4.83

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

107

2.54

4.79

1.1

1.5

nmol/l

150.6

138.8

0.58

107

(3040151) Glucose [Moles/volume] in Capillary blood

176

2.18

4.78

3.3

6.1

mmol/l

7.5

7.2

0.16

150

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

11.46

4.78

1.0

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

11.46

4.78

1.1

mmol/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.89

4.76

2.4

2.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.80

4.71

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

232

2.00

4.65

1.5

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

621

1.60

4.62

1.3

1.1

—

(3008295) Osmolality of Serum or Plasma

193

2.09

4.56

2.2

1.5

mosm/kgh2o

286.7

284.5

0.21

151

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

306

1.85

4.49

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

395

1.74

4.46

1.7

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

630

1.58

4.37

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

252

1.92

4.35

1.4

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

376

1.75

4.34

1.4

1.3

u/l

15.8

19.8

0.43

310

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

101

2.49

4.29

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

145

2.22

4.27

1.3

2.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

145

2.22

4.27

1.3

2.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

145

2.22

4.27

1.3

2.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

583

4970

1.22

4.27

2.8

2.4

umol/l

345.5

3975.4

10.16

513

4478

(3014765) Yersinia sp identified in Stool by Organism specific culture

626

1.57

4.26

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.05

4.24

1.3

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

262

1.89

4.22

1.1

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

179

2.08

4.21

3.2

2.1

13.1

13.3

0.03

(40768446) Kidney Pathology biopsy report

2.49

4.13

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

430

1.67

4.04

3.1

2.5

nmol/l

1.0

0.9

0.55

374

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

2.29

4.03

1.2

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

203

1.99

4.02

1.5

2.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.45

3.98

4.8

2.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.45

3.98

1.6

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

131

2.23

3.92

1.3

1.6

—

(3011412) CD3 cells [#/volume] in Blood

226

1.92

3.92

3.3

2.7

e9/l

1.4

1.2

0.30

131

(3019225) pH of Specimen

196

1474

1.36

3.90

4.0

3.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

116

1656

0.69

3.85

1.4

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

152

2.12

3.84

2.7

1.5

—

(3023419) Bacteria identified in Sputum by Culture

200

1.96

3.82

2.0

2.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

331

1.74

3.79

2.8

2.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

180

2.01

3.79

1.4

2.1

—

(3044941) Cell count panel - Synovial fluid

265

1.83

3.78

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

392

1.68

3.78

1.7

e6/l

16458.8

14843.0

0.11

290

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.01

3.68

2.9

4.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

404

1.65

3.64

1.2

1.3

—

(3024471) HLA-A [Type]

2.43

3.63

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

3.63

0.0

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

170

1267

1.37

3.60

1.3

1.4

iu/l

23.2

22.1

0.17

120

1064

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.75

3.58

4.9

1.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

2.26

3.55

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1136

0.64

3.54

1.8

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

120

850

1.43

3.43

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

146

2.07

3.42

3.6

2.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

113

2.22

3.41

1.5

1.6

nmol/l

1.4

1.3

0.19

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

404

4772

0.82

3.38

3.2

3.1

24.2

21.1

1.74

120

1654

(3003888) Timothy IgE Ab [Units/volume] in Serum

587

0.52

3.32

1.2

1.1

u/ml

4.0

7.1

0.80

307

(3024932) HLA-DR beta [Type]

2.37

3.31

1.0

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.42

3.30

7.0

1.7

155.6

151.8

0.08

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

384

1.63

3.30

1.2

—

9.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

156

2.00

3.24

2.7

3.4

49.8

54.5

0.42

108

(1002224) Polysomnography panel

1360

0.69

3.24

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.45

3.21

1.3

1.1

—

(40768443) Skin Pathology biopsy report

104

727

1.45

3.21

1.3

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

157

1.99

3.19

1.6

2.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

172

1311

1.33

3.18

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

172

1.93

3.14

2.5

2.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

449

0.49

2.99

1.2

1.1

u/ml

9.4

4.2

0.42

183

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

184

1.86

2.92

1.4

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

559

0.55

2.87

1.2

1.1

u/ml

0.7

2.1

—

136

(21494814) CD8 cells/100 lymphocytes in Specimen

2.26

2.86

4.8

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.30

2.84

1.3

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.40

2.80

1.0

1.3

—

72.2

—

(3021788) Differential panel - Synovial fluid

292

1.66

2.79

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

409

0.49

2.76

1.2

1.0

u/ml

0.1

0.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.87

2.75

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.32

2.74

1.4

1.1

98.3

89.6

0.75

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

218

1.75

2.72

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

160

1.89

2.71

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.60

2.70

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.22

2.67

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.76

2.67

6.6

4.4

mmol/l

5.7

7.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

482

0.53

2.66

1.2

1.1

u/ml

4.1

3.8

0.04

187

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

2.34

2.65

1.0

1.3

—

1314.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.13

2.64

2.3

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

556

0.57

2.62

1.2

1.1

u/ml

0.2

1.0

2.33

230

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

166

1297

1.30

2.62

2.5

3.4

pmol/l

4.5

4.6

0.40

138

1172

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

282

1.64

2.61

1.3

1.2

u/l

57.7

35.1

0.36

238

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

638

0.61

2.54

1.3

1.1

u/ml

1.6

1.8

0.10

253

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.17

2.51

3.7

1.8

umol/l

1.9

2.0

0.13

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.27

2.51

1.5

1.3

97.2

89.7

0.48

(3011985) Renin [Units/volume] in Plasma

232

1.69

2.49

1.4

1.5

mu/l

104.4

52.6

0.48

209

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

956

0.68

2.46

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.67

2.45

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

145

1.87

2.41

2.7

2.8

nmol/l

1.1

0.8

0.74

105

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.35

2.38

1.3

3.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.35

2.38

2.6

umol/l

26.5

30.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.35

2.38

1.3

3.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

6.26

2.37

1.2

1.1

u/l

12.2

8.1

—

(3035880) pH of Pleural fluid

2.51

2.36

1.3

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.46

2.27

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

632

1.39

2.26

1.6

1.9

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.90

2.25

1.3

1.4

nmol/l

13.7

32.1

—

(3045716) Anion gap in Serum or Plasma

2.10

2.22

1.6

2.1

mmol/l

7.8

9.0

1.15

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

311

1.55

2.22

1.2

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.20

2.21

2.2

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

196

0.41

2.17

5.0

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

196

0.41

2.17

2.5

3.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

307

3569

0.84

2.15

2.2

2.4

ug/l

0.5

0.6

3.21

205

1874

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.30

2.14

1.5

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

412

1.47

2.13

1.4

1.2

—

(3002256) Pathology report gross observation

268

2269

1.20

2.12

1.3

1.2

—

(3000012) Reticulocyte production index

2.21

2.11

1.3

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1979

20382

0.88

2.10

3.8

3.4

mmol/l

1.4

0.45

1818

19349

(3043238) Trisomy 21 risk [Likelihood] in Fetus

747

0.68

2.07

1.6

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.51

2.05

1.0

1.2

—

(3042733) HLA Ab [Presence] in Serum

1.99

2.05

2.3

4.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

154

1.76

2.04

1.4

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

231

1.61

2.02

1.4

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

384

1.47

2.02

1.0

1.1

105.1

113.8

1.35

358

(3015183) Erythrocyte sedimentation rate

160

0.37

2.01

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

218

2597

0.82

2.01

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.82

2.00

2.1

2.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

728

0.68

1.98

1.6

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.29

1.97

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

141

1.78

1.96

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

156

1.74

1.96

3.1

3.0

mg/l

99.1

53.1

0.39

111

(3002523) Influenza virus A Ag [Presence] in Specimen

559

0.64

1.95

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

559

0.64

1.95

1.1

—

(3005033) Fetal Nuchal fold Thickness US

725

0.68

1.94

1.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

480

1.41

1.93

2.6

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.25

1.90

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

456

1.41

1.90

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.16

1.88

1.3

3.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

136

1.77

1.87

1.4

2.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.65

1.86

1.4

2.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

159

1.71

1.85

1.6

1.3

e6/l

35678.7

81633.2

0.49

114

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.21

1.84

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.17

1.82

1.6

2.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

394

1.43

1.80

1.1

iu/ml

142.4

1245.1

—

111

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

287

1.51

1.79

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

712

0.70

1.78

1.8

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

885

0.73

1.78

1.5

1.4

—

(4094501)

522

0.65

1.77

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

884

0.73

1.77

1.5

1.4

—

(3000492) Spirometry study

279

2413

1.18

1.76

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

396

1.42

1.76

1.3

u/ml

3.1

5.4

0.92

134

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

882

0.73

1.75

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

880

0.73

1.72

1.5

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.85

1.71

1.4

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.14

1.71

4.5

2.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

163

1.66

1.71

2.0

mg/l

24.3

21.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

171

1.64

1.70

2.1

2.9

e6/l

794.4

541.7

0.74

147

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

156

1.67

1.69

1.8

1.4

22.6

32.3

0.80

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1080

0.76

1.69

1.4

1.7

mg/l

4.3

4.0

0.08

735

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

227

1.55

1.68

1.2

1.5

pmol/l

274.8

333.3

0.62

172

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

737

0.71

1.67

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.80

1.65

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

127

1.74

1.64

2.1

1.6

mg/l

4.3

3.7

0.23

122

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

113

1.78

1.60

2.0

1.5

u/l

6.9

3.6

0.43

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.50

1.59

1.1

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.01

1.59

1.4

2.2

e6/l

140.0

198.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

614

0.70

1.59

1.3

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

397

1.39

1.57

1.2

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

156

1297

1.22

1.55

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.89

1.55

1.3

2.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.89

1.55

1.3

2.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.89

1.55

1.3

2.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

249

1.49

1.52

2.2

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

193

1.56

1.51

1.7

1.6

74.9

57.5

1.69

123

(3003694) ABO and Rh group [Type] in Blood

689

6391

1.11

1.49

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

393

1.38

1.48

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2067

21118

0.90

1.46

4.2

3.7

mmol/l

1.3

1.4

19.56

1909

20083

(3045142) Bone marrow Pathology biopsy report

171

1.59

1.46

1.4

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1787

17334

1.10

1.45

3.7

3.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

236

1.49

1.44

1.5

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

164

1.59

1.43

2.2

3.0

e9/l

0.2

0.12

144

(3035320) C reactive protein [Mass/volume] in Body fluid

133

1.66

1.42

1.8

2.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

448

1.35

1.42

1.2

u/ml

21.8

46.8

—

(4034850)

626

1.29

1.37

13.0

7.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

818

7679

1.10

1.37

4.0

3.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

264

1.45

1.36

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.94

1.36

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.94

1.36

1.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.94

1.36

1.0

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

240

1.46

1.34

1.5

2.1

nmol/l

17.5

20.2

0.86

229

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

1.34

0.0

1.2

—

7.0

—

(3009871) Measles virus Ab [Titer] in Serum

105

1.72

1.33

1.5

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

515

1.31

1.32

1.2

u/ml

9.3

9.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

648

1.27

1.32

2.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

508

1.31

1.29

1.2

u/ml

3.5

2.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

1.70

1.29

1.3

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

483

1.31

1.27

2.1

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1080

0.80

1.27

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.09

1.27

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.05

1.26

1.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

219

1.47

1.26

3.0

3.9

u/ml

21.4

26.5

0.32

214

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.77

1.23

1.3

2.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

391

1.34

1.21

1.3

u/ml

4.6

5.1

0.10

184

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.17

1.21

1.6

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.80

1.21

1.7

1.3

1.7

3.7

—

(4306422)

400

1.33

1.21

1.1

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.11

1.18

2.6

1.7

mmol/l

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.11

1.18

1.0

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

117

1.63

1.18

1.4

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

117

1.63

1.18

2.5

1.6

umol/l

15.6

30.0

2.01

109

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

333

0.66

1.16

1.2

1.4

pmol/l

36.2

159.9

—

108

(3017569) Oxygen content in Arterial blood

1.81

1.15

3.1

2.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

590

1.26

1.14

1.9

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.26

1.10

1.0

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

112

1.61

1.08

1.0

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

144

1.53

1.08

3.3

2.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2084

21205

0.91

1.08

4.2

3.8

mmol/l

4.4

4.8

47.66

1928

20232

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.28

1.03

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

405

0.71

1.03

1.2

1.1

—

11.8

—

(40757373) Influenza virus identified in Isolate

2.06

1.03

1.6

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.06

1.03

1.4

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

809

0.80

1.02

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

1.92

1.02

2.9

2.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

131

1.53

0.99

1.7

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

405

1.29

0.99

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

739

0.79

0.99

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.84

0.98

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

158

0.57

0.98

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.18

0.98

1.2

3.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

190

1.43

0.96

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.96

0.0

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

340

0.70

0.94

1.2

1.3

mmol/l

6.9

0.01

245

(4268621)

277

1.34

0.93

2.2

2.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.22

0.93

1.8

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

142

0.56

0.93

1.4

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

321

1.31

0.93

4.0

3.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.67

0.91

1.0

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

375

1.29

0.91

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

118

1.53

0.90

1.2

1.1

miu/ml

1571.9

1460.3

0.15

118

(1761482) Bacteria [#/volume] in Urine by Culture

340

1.30

0.90

5.6

3.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

227

1.37

0.90

1.5

1.3

nmol/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.58

0.87

1.3

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.00

0.87

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

778

1.19

0.86

1.5

1.6

iu/ml

0.4

0.3

0.23

143

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.78

0.84

1.6

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

179

1.40

0.84

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.70

0.80

7.4

5.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

149

0.60

0.79

1.3

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

110

954

1.16

0.78

1.8

2.1

u/l

47.0

40.0

1.60

101

880

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

395

0.76

0.78

1.1

u/ml

5.1

2.2

—

216

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

751

1.18

0.77

2.4

2.2

—

(40768804) Tissue Pathology biopsy report

794

7602

1.06

0.76

2.0

1.9

—

(3008898) HLA-B27 [Presence]

1005

0.85

0.76

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.52

0.75

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.74

1.1

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.67

0.74

1.4

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.75

0.71

2.0

1.3

9.0

1.7

—

(3000330) Specific gravity of Urine by Test strip

748

1.17

0.71

4.1

2.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

832

1.16

0.71

1.2

1.3

u/ml

0.3

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.92

0.70

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.53

0.69

1.8

—

(3004451) EKG impression Narrative

1.53

0.69

1.5

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.53

0.68

1.1

1.4

—

(4027681)

187

1.34

0.68

1.2

1.3

—

(40768800) Prostate Pathology biopsy report

261

0.73

0.67

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.63

0.66

1.3

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

214

1.31

0.66

1.1

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.54

0.65

1.2

1.4

—

(3028433) Virus identified in Specimen by Culture

1.62

0.65

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

215

1.31

0.65

1.1

1.4

mmol/l

14.3

12.3

0.61

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.48

0.64

1.4

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

315

2941

1.08

0.64

2.4

2.7

ug/g

124.9

133.5

0.18

256

2412

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

1.73

0.64

7.2

8.7

umol/l

0.2

0.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

561

5346

1.06

0.63

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

212

0.71

0.63

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

175

0.68

0.60

1.4

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

218

1.29

0.60

1.1

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.50

0.59

1.2

1.4

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.59

0.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

174

0.69

0.59

1.4

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.56

0.58

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

581

6069

0.95

0.58

3.2

3.5

ug/l

2.1

1.8

0.17

495

5570

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

2.2

—

123.0

—

(3025941) Bacteria identified in Stool by Culture

145

1315

1.11

0.57

1.4

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

123

0.65

0.54

1.0

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.54

0.53

2.0

2.8

—

185.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.45

0.53

2.7

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.43

0.53

1.1

—

(3017704) Immunofixation for Urine

1.52

0.52

1.5

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

214

1.26

0.52

1.1

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.46

0.50

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

399

0.82

0.48

1.3

ug/l

3.1

3.2

0.10

370

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

217

1.25

0.48

1.1

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

217

1.25

0.48

1.1

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

217

1.25

0.48

1.1

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

210

0.76

0.46

2.4

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.59

0.45

1.4

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

147

1.29

0.45

1.3

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

242

0.78

0.44

1.2

1.6

mmol/l

7.2

7.5

0.28

144

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

151

1394

1.09

0.44

1.2

1.3

au/ml

30.2

45.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

384

0.83

0.44

1.3

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

121

1.32

0.44

2.1

2.6

umol/l

45.3

51.1

0.31

105

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

345

3287

1.06

0.42

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

221

1.22

0.42

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

604

1.13

0.42

1.7

2.2

mg/l

13.8

10.1

2.06

566

(3032868) Hemoglobin electrophoresis panel in Blood

1.52

0.41

1.6

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.41

0.0

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

114

1.32

0.40

4.6

7.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

259

1.20

0.40

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.47

0.40

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.43

0.39

1.0

1.3

mg/l

1.0

328.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

707

0.89

0.39

1.5

1.3

—

(4146454)

151

1.26

0.38

2.9

2.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

225

0.80

0.38

1.5

—

(3024263) Appearance of Synovial fluid

1.35

0.38

1.2

1.9

—

(3034426) Prothrombin time (PT)

1.33

0.37

1.0

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

112

0.71

0.37

1.1

2.4

ug/l

16.8

298.2

—

101

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

351

3366

1.05

0.36

1.3

u/ml

7.9

10.2

0.32

1466

(3008536) Aspergillus sp Ab [Presence] in Serum

1.43

0.35

1.3

2.9

—

(3014051) Protein [Presence] in Urine by Test strip

385

1.15

0.35

1.7

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.62

0.35

1.0

1.1

—

(3022145) Colonoscopy Study observation

228

2163

1.06

0.35

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.32

0.33

1.3

1.5

u/field

1.3

4.0

0.75

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.27

0.30

1.9

1.2

50.4

50.2

—

(40768795) Lymph node Pathology biopsy report

166

1.21

0.29

1.9

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

231

1.17

0.29

1.2

mg/l

48.9

41.9

0.22

187

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

411

1.12

0.29

2.5

2.6

ug/min

249.3

140.6

0.40

267

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

450

1.11

0.28

1.3

1.5

nmol/l

0.2

0.4

3.41

367

(3035933) Granulocytes/100 leukocytes in Blood

1.30

0.28

8.5

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

142

1503

0.94

0.27

1.2

1.3

u/ml

307.3

241.7

0.18

132

1399

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

149

1574

0.94

0.27

1.2

iu/ml

121.4

141.9

0.20

622

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

209

1998

1.05

0.26

3.8

3.7

30.5

30.0

0.31

151

1479

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.68

0.26

1.8

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.71

0.24

1.3

1.0

—

(21494434) Karyotype in Bone marrow

124

1.21

0.24

1.1

1.3

—

(3017732) Neutrophils [#/volume] in Blood

149

1418

1.05

0.23

2.9

2.5

e9/l

4.2

0.00

112

1199

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

134

1.20

0.23

1.8

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

1.25

0.22

6.4

12.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.27

0.22

3.4

3.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

210

0.86

0.22

1.2

1.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

229

1.14

0.21

1.1

1.3

g/l

6.8

6.7

0.06

159

(3024139) IgG subclass 3 [Mass/volume] in Serum

229

1.14

0.21

1.1

1.3

g/l

0.5

0.4

0.69

157

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.19

0.21

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.19

0.21

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.19

0.21

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.19

0.21

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

4.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.3

—

40.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

4.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

230

1.13

0.20

1.1

1.3

g/l

2.8

3.1

0.28

159

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

222

1.13

0.19

1.1

mg/l

208.0

268.4

2.32

192

(40768793) Breast Pathology biopsy report

343

0.90

0.19

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.13

0.18

2.2

ug/l

41.7

56.5

—

(4062490)

232

1.12

0.18

1.1

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2148

21384

1.03

0.18

4.6

4.0

mmol/l

2.7

2.9

31.23

1977

20269

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.76

0.17

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.76

0.17

1.2

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

661

1.06

0.16

1.1

u/ml

1.6

3.8

—

105

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

535

1.07

0.16

1.8

2.0

iu/l

2.8

4.4

2.32

200

(3022621) pH of Urine by Test strip

119

1143

1.04

0.15

2.5

2.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

431

1.07

0.14

1.5

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

377

0.93

0.13

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.16

0.11

1.6

1.5

—

8.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

147

0.88

0.11

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

579

5726

1.01

0.10

3.6

2.7

—

(3044927) Protein electrophoresis panel - Urine

125

0.88

0.10

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.06

0.09

1.6

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

155

1516

1.02

0.09

2.2

2.3

au/ml

40.2

19.6

—

125

(3006462) Nitrate [Presence] in Urine

0.86

0.07

2.2

2.6

—

(4024509)

112

0.89

0.07

1.5

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.87

0.07

1.0

1.2

140.3

107.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.83

0.07

1.0

—

(3045414) Leukocytes [Presence] in Urine

812

0.97

0.07

1.6

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.02

0.07

1.6

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

128

1.09

0.06

1.1

—

43.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

172

0.93

0.06

1.2

1.3

u/ml

0.0

0.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

120

1.08

0.05

1.0

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

130

1.08

0.04

1.1

1.2

—

91.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

130

1.08

0.04

1.1

1.2

—

65.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

149

0.94

0.03

1.0

1.2

ratio

1.2

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

161

1.06

0.03

3.8

4.0

mu/l

25.3

35.0

0.63

156

(3045683) HLA typing for celiac disease panel - Blood or Tissue

167

0.96

0.01

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

657

0.99

0.01

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

804

1.01

0.00

2.1

2.5

u/ml

40.2

41.3

0.03

778

(44813793)

165

1.03

0.00

1.2

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

369

1.00

0.00

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

809

1.00

0.00

1.9

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

127

1269

1.00

0.00

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

214

0.98

0.00

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

384

0.99

0.00

4.1

3.2

mg/l

20.9

23.6

0.17

235

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

2.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

150.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.96

0.00

3.2

2.7

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.8

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

143.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

501.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.91

0.00

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.89

0.00

1.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3045424) Erythrocytes [Presence] in Urine

320

1.00

0.00

1.5

1.4

—

(4211845)

1.00

0.00

1.9

2.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

2.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.99

0.00

4.3

3.2

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

1.3

—

1015.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.86

0.00

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

11.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.9

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: AB1_HEPATITIS_OTHER_VIRAL – Other viral hepatitis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other viral hepatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other viral hepatitis (AB1_HEPATITIS_OTHER_VIRAL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints